Day Trader: High Volatility Stocks for Active Trading (TA&FA) Generate 13.73% for OCGN
OCGN, an engaging target for day traders, has recently shown significant movement in the market, generating a 13.73% return. This stock has proven to be a compelling asset in active trading, particularly due to its high volatility, making it a particularly suitable candidate for traders who thrive in dynamic market conditions.
Notably, OCGN's Moving Average Convergence Divergence (MACD) histogram just turned positive on June 12, 2023. This is an intriguing development for day traders who rely on this indicator as a valuable tool for spotting potential buying opportunities. A positive MACD often indicates an upward price trend, meaning the stock may offer promising returns.
Historical analysis of OCGN further strengthens this prediction. Past records show that whenever the MACD for OCGN turned positive, the stock continued to rise in 47 out of 52 cases over the following month. This translates to an impressive success rate of approximately 90%.
These figures reflect the potential robustness of using the MACD as an indicator for buying opportunities with OCGN. The historical consistency of the stock's positive response to a positive MACD histogram underlines the potential for continued growth in the short term.
The high volatility of OCGN combined with its recent positive MACD provides an exciting proposition for day traders. These traders can potentially benefit from both the rapid price swings inherent in high-volatility stocks and the predictive power of a positive MACD.
OCGN is a stock that day traders should consider monitoring closely, given its high volatility and the recent positive shift in its MACD. As historical trends suggest, there's a significant chance that OCGN will continue to provide robust returns, making it an attractive option for active trading.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OCGN's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for OCGN just turned positive on August 29, 2023. Looking at past instances where OCGN's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on September 07, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on OCGN as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for OCGN entered a downward trend on September 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OCGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.444) is normal, around the industry mean (22.643). P/E Ratio (0.000) is within average values for comparable stocks, (131.410). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.929). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (308.526).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the development and commercialization of therapies for eye diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To OCGN | 1D Price Change % | ||
---|---|---|---|---|
OCGN | 100% | +1.11% | ||
BEAM - OCGN | 53% Loosely correlated | -1.07% | ||
NTLA - OCGN | 53% Loosely correlated | -1.38% | ||
MDGL - OCGN | 51% Loosely correlated | -1.18% | ||
VXRT - OCGN | 51% Loosely correlated | -4.09% | ||
AGIO - OCGN | 50% Loosely correlated | +1.38% | ||
More |